RESUMEN
Background: Traditionally, graduates from colleges of pharmacy in Saudi Arabia work mainly in hospital settings, and only a few graduates work in other practice settings. However, several initiatives and national plans have recently been introduced to facilitate employment in community pharmacies and the pharmaceutical industry/companies. Consequently, the objectives of this study were to explore the current state of career placement, type of employment sectors, and practice settings that Doctor of Pharmacy (PharmD) graduates join based on recent developments in the profession. Methods: This study is a cross-sectional, descriptive study. The target population was PharmD graduates from Unaizah College of Pharmacy, Qassim University, Saudi Arabia. Consequently, all 162 graduates from three recent cohorts (2018-2020) were contacted to participate in this survey. Results: A total of 157 graduates participated in this study, yielding a response rate of 96.91 %. Of the participants, 92 (58.6 %) were female graduates. The overall rate of employment was 84.7 %. Moreover, a higher proportion of male graduates than female graduates (97.1 % versus 73.7 %, P = 0.006) were employed. In this study, the three main sectors that the graduates joined were the pharmaceutical industry and companies (41.2 %), community pharmacies (29.4 %), and medical cities, hospitals and clinics (23.5 %). In addition, almost the same proportions of male and female graduates joined the pharmaceutical industry and companies (40.3 % versus 42.1 %). However, a higher proportion of male graduates than female graduates joined community pharmacies (32.3 % versus 26.3 %). Conversely, a higher proportion of female graduates joined medical cities, hospitals and clinics compared to male graduates (28.1 % versus 19.4 %). Conclusion: The current employment of PharmD graduates in the job market is generally high, but further improvement could be made, especially for female graduates. Moreover, the study findings showed that jobs are shifting toward community pharmacies and the pharmaceutical industry. Therefore, we believe that decision-makers in pharmacy education and curriculum developers must consider these trends and ensure that there is adequate preparation for careers in community pharmacy practice and other sectors of the profession in the curriculum.
RESUMEN
OBJECTIVE: To determine the dominant arterial supply to the scrotum. STUDY DESIGN: Experimental anatomic study. ANIMALS: Intact male canine cadavers (n = 10). METHODS: Barium sulfate was injected into the internal iliac artery (n = 7) or into the pudendoepigastric trunk (n = 3). The perineal, scrotal, and prescrotal skin was sharply dissected from cadavers and radiographed. Angiograms were subjectively reviewed by 3 investigators. RESULTS: Angiograms were completed successfully in all 10 dogs, with no difference between frozen and fresh cadavers. The dominant blood supply to the scrotum was consistently identified as arising from the ventral perineal arteries, originating from the internal pudendal arteries, coursing ventrally and cranially toward the caudal scrotum before terminating as the dorsal scrotal arteries (n = 7). The blood supply to the cranial scrotum was more limited (n = 3) as only the cranial border of the scrotum was perfused by the ventral scrotal arteries. CONCLUSION: Based on this anatomic perfusion study, the dorsal scrotal arteries appear to supply a larger area than the ventral scrotal arteries. CLINICAL SIGNIFICANCE: These results provide evidence to justify further consideration of a scrotal flap using the caudal perineal skin as the main cutaneous pedicle to reconstruct defects located on the caudal, medial, and lateral thighs in dogs. Such a flap should be based on the caudal blood supply and the base of this flap should be located caudal to the scrotum to preserve its main blood supply.
Asunto(s)
Enfermedades de los Perros , Escroto , Angiografía/veterinaria , Animales , Arterias , Cadáver , Perros , Humanos , Masculino , Escroto/cirugía , Colgajos Quirúrgicos/veterinariaRESUMEN
Glaucoma disease is optic neuropathy; in glaucoma, the optic nerve is damaged because the long duration of intraocular pressure can be caused blindness. Nowadays, deep learning classification algorithms are widely used to diagnose various diseases. However, in general, the training of deep learning algorithms is carried out by traditional gradient-based learning techniques that converge slowly and are highly likely to fall to the local minimum. In this study, we proposed a novel decision support system based on deep learning to diagnose glaucoma. The proposed system has two stages. In the first stage, the preprocessing of glaucoma disease data is performed by normalization and mean absolute deviation method, and in the second stage, the training of the deep learning is made by the artificial algae optimization algorithm. The proposed system is compared to traditional gradient-based deep learning and deep learning trained with other optimization algorithms like genetic algorithm, particle swarm optimization, bat algorithm, salp swarm algorithm, and equilibrium optimizer. Furthermore, the proposed system is compared to the state-of-the-art algorithms proposed for the glaucoma detection. The proposed system has outperformed other algorithms in terms of classification accuracy, recall, precision, false positive rate, and F1-measure by 0.9815, 0.9795, 0.9835, 0.0165, and 0.9815, respectively.
Asunto(s)
Aprendizaje Profundo , Glaucoma , Algoritmos , Glaucoma/diagnóstico , Humanos , Presión IntraocularRESUMEN
BACKGROUND: Preterm birth is the most common cause of neonatal morbidity and mortality. Tocolytics are considered a standard treatment for women with threatened preterm delivery to allow time for maternal steroid administration and transfer to referral centers with neonatal intensive care units. However, there is controversy about the best tocolytic therapy to be considered as the first choice. The aim of this study is to compare the tocolytic effectiveness and tolerability of combination therapy with nifedipine and indomethacin versus nifedipine monotherapy among Sudanese women with preterm labor (PTL) as well as to compare the possible neonatal outcomes associated with each drug. METHODS/DESIGN: This is a randomized controlled clinical trial to be conducted in the Medani Maternity Hospital, Sudan. Women aged 18-40 years that are diagnosed with preterm labor and have a gestational age between 25 and 34 weeks will be eligible to participate in this trial. The diagnosis of threatened PTL is defined as persistent uterine contractions "(four contractions every 20 min or eight contractions every 60 min)" with cervical changes "(cervical effacement ≤80% or cervical dilatation >two cm)". Patients will be eligible regardless of the presentation of the fetus. It will be randomly decided whether participants receive nifedipine/indomethacin combination therapy or nifedipine monotherapy. The primary outcome is the number of women who do not deliver and do not need alternative tocolytic drug (terbutaline). The secondary outcome is an estimated association with neonatal morbidity and mortality. The sample size will be 117 subjects in each arm of the study, according to a type I error of 0.05 and a study power of 80%. DISCUSSION: We expect higher effectiveness of the combination indomethacin/nifedipine tocolytic therapy compared with nifedipine monotherapy. We plan to suggest this combination therapy as the best option for postponing PTL. TRIAL REGISTRATION: Clinical trial registration: PACTR202004681537890 , date of registration: March 8, 2020.
Asunto(s)
Indometacina/uso terapéutico , Nifedipino/uso terapéutico , Nacimiento Prematuro/tratamiento farmacológico , Tocólisis/métodos , Tocolíticos/uso terapéutico , Adolescente , Adulto , Terapia Combinada , Femenino , Edad Gestacional , Humanos , Recién Nacido , Primer Periodo del Trabajo de Parto , Embarazo , Ensayos Clínicos Controlados Aleatorios como Asunto , Sudán , Adulto JovenRESUMEN
OBJECTIVE: To evaluate the efficacy of blastocyst culture and transfer in human in vitro fertilization (IVF) as compared to day 3 embryo transfer. DESIGN: Prospective randomized trial. SETTING: Private assisted reproduction unit. PATIENT(S): A total of 162 IVF patients were included in the day 3 embryo transfer (n = 82) and blastocyst transfer (n = 80) groups. INTERVENTION(S): Embryo transfer on day 3 after culture in the standard culture media and blastocyst transfer on day 5 or 6 after culture in the sequential culture media. MAIN OUTCOME MEASURE(S): Implantation and pregnancy rates, multiple gestation rate. RESULT(S): The implantation rate for embryos transferred at the blastocyst stage was significantly higher than that for embryos transferred on day 3 (26% vs. 13%). The viable pregnancy rate was similar in both groups (29% vs. 26%). Significantly fewer embryos were required for transfer at the blastocyst stage compared with day 3 embryo transfer (2.0 +/- 0.1 vs. 3.5 +/- 0.63). The high-order multiple gestation rate was significantly less with the blastocyst transfer than with the day 3 embryo transfer (4% vs. 19%). CONCLUSION(S): With the use of blastocyst culture, a few embryos can be transferred without decreasing the overall pregnancy rate. This may reduce multiple gestations and improve human IVF outcome.